Trial intelligence / Profile preview

Cognitive Effects of Risperidone and Olanzapine

NCT00108368Phase 4Completed

Sponsor
United States Department of Veterans Affairs
Start
Oct 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of risperidone in schizophrenia, sponsored by United States Department of Veterans Affairs. Started Oct 2003; status: completed.

02

Drugs

risperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00108368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00108368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call